0.31
+0.0664(+27.71%)
Currency In USD
Address
188 Grand Street, Unit 195
Humacao, NY 10013
United States of America
Phone
N/A
Website
Sector
Healthcare
Industry
Biotechnology
Employees
2
First IPO Date
April 11, 2022
| Name | Title | Pay | Year Born |
| Mr. Kraig T. Higginson | President, Chief Executive Officer & Chairman of Board | 0 | 1956 |
| Mr. Stephen E. Quesenberry | General Counsel & Corporate Secretary | 0 | 1963 |
| Mr. Ernest J. Scheidemann Jr. | Chief Financial Officer | 0 | 1961 |
Aspire Biopharma Holdings, Inc. is a biotechnology company specializing in advanced diagnostic solutions and molecular testing. The company focuses on developing high-precision assays for disease detection, leveraging cutting-edge research in genetics and biochemistry to support healthcare and life sciences industries.